A CDC report said that, overall, fentanyl continues to drive drug overdose deaths, but in almost half of the country, methamphetamine is the leading killer; backers of Medicaid expansion in Oklahoma said they submitted more than enough signatures to get the measure on the ballot in 2020; the Federal Trade Commission is suing publishers of "The Doctor's Guide to Reversing Diabetes in 28 Days" on the grounds that they are falsely promising a cure without dietary changes or exercise and stating that those changes will make diabetes worse.
A CDC report said that, overall, fentanyl continues to drive drug overdose deaths, but in almost half of the country, methamphetamine is the leading killer. Across the United States, methamphetamine is the fourth leading killer, cited in 13% of overdose deaths. But in 4 western regions, it is number 1, at 21% to 38%, The Associated Press reported.Backers of Medicaid expansion in Oklahoma said they submitted more than enough signatures to get the measure on the ballot in 2020. Supporters estimate that almost 200,000 people in Oklahoma stand to gain coverage if the effort succeeds, The Hill reported. The "Yes on 802" campaign said it submitted more than 313,000 signatures, far more than the roughly 178,000 it needed, The Hill reported. Utah, Idaho, and Nebraska voters approved ballot measures approving Medicaid expansion in last year’s elections. The Oklahoma Council of Public Affairs, a conservative think tank in the state, has vowed an opposition effort.
The Federal Trade Commission is suing publishers of "The Doctor's Guide to Reversing Diabetes in 28 Days" on the grounds that they are falsely promising a cure without dietary changes or exercise and stating that those changes will make diabetes worse. The publications claim a "shocking, hidden cause" of type 2 diabetes is exposure to electronic devices, such as computers, televisions, and cellphones. Five Baltimore-based companies, including Agora Financial LLC and NewMarket Health LLC, and 2 men identified as editors, are named as defendants, The Associated Press reported.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program
October 3rd 2025This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Read More